Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

473 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tysabri raises alarm bells on drug class.
Sheridan C. Sheridan C. Nat Biotechnol. 2005 Apr;23(4):397-8. doi: 10.1038/nbt0405-397. Nat Biotechnol. 2005. PMID: 15815649 No abstract available.
Fast track to MS drug.
Sheridan C. Sheridan C. Nat Biotechnol. 2004 Aug;22(8):939-41. doi: 10.1038/nbt0804-939. Nat Biotechnol. 2004. PMID: 15286635 No abstract available.
Third Tysabri adverse case hits drug class.
Sheridan C. Sheridan C. Nat Rev Drug Discov. 2005 May;4(5):357-8. doi: 10.1038/nrd1743. Nat Rev Drug Discov. 2005. PMID: 15902765 No abstract available.
Tysabri back on market.
Sheridan C. Sheridan C. Nat Biotechnol. 2006 Aug;24(8):874. doi: 10.1038/nbt0806-874. Epub 2006 Aug 3. Nat Biotechnol. 2006. PMID: 16900111 No abstract available.
Tysabri risk causing headache for companies.
Sheridan C. Sheridan C. Nat Rev Drug Discov. 2005 Sep;4(9):703-4. doi: 10.1038/nrd1837. Nat Rev Drug Discov. 2005. PMID: 16178114 No abstract available.
TeGenero fiasco prompts regulatory rethink.
Sheridan C. Sheridan C. Nat Biotechnol. 2006 May;24(5):475-6. doi: 10.1038/nbt0506-475. Nat Biotechnol. 2006. PMID: 16680111 No abstract available.
473 results